Gender differences in 12-week antidepressant treatment outcomes for a naturalistic secondary care cohort: The CRESCEND study

Psychiatry Research

Volumn 189, Issue 1, 2011, Pages 82-90

  Yang, Su Jin ^a   Kim, Sun Young ^a   Stewart, Robert ^b   Kim, Jae Min ^a   Shin, Il Seon ^a   Jung, Sung Won ^c   Lee, Min Soo ^d   Jeong, Seung Hee ^e   Jun, Tae Youn ^e  

^a Chonnam National University Medical School   (South Korea)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Keimyung University   (South Korea)

^d Korea University College of Medicine   (South Korea)

^e The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Antidepressants; Depression; Gender differences; Korea; Treatment outcome

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMISULPRIDE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BROMAZEPAM; CITALOPRAM; CLOMIPRAMINE; ESCITALOPRAM; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; LAMOTRIGINE; LITHIUM; MILNACIPRAN; MIRTAZAPINE; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; PERPHENAZINE; PIMOZIDE; QUETIAPINE; RISPERIDONE; SERTRALINE; TIANEPTINE; TRAZODONE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; ZIPRASIDONE;

ANXIETY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; EDUCATIONAL STATUS; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MENOPAUSE; MULTICENTER STUDY; PRIORITY JOURNAL; SEX DIFFERENCE; SOCIAL INTERACTION; SOUTH KOREA; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; COHORT STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; MENOPAUSE; MIDDLE AGED; PROBABILITY; PSYCHIATRIC STATUS RATING SCALES; REPUBLIC OF KOREA; SEX CHARACTERISTICS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79958096715     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2010.12.027     Document Type: Article

References (49)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Press, Washington, DC. 4th ed.
2. Baca E., Garcia-Garcia M., Porras-Chavarino A. Gender differences in treatment response to sertraline versus imipramine in patients with non-melancholic depressive disorders. Progress in Neuro-psychopharmacology Biological Psychiatry 2004, 28:57-65.
3. Bethea C.L., Lu N.Z., Gundlah C., Streicher J.M. Diverse actions of ovarian steroids in the serotonin neural system. Frontiers in Neuroendocrinology 2002, 23:41-100.
4. Bigos K.L., Pollock B.G., Stankevich B.A., Bies R.R. Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review. Gender Medicine 2009, 6:522-543.
5. Burger H., Woods N.F., Dennerstein L., Alexander J.L., Kotz K., Richardson G. Nomenclature and endocrinology of menopause and perimenopause. Expert Review of Neurothearpeutics 2007, 7(11 suppl):S35-S43.
6. Cho M.J., Kim J., Jeon H.J., Suh T., Chung I., Hong J.P., Bae J., Lee D., Park J., Cho S., Lee C.J., Hahm B. Lifetime and 12-month prevalcence of DSM-IV psychiatric disorders among Korean adults. Journal of Nervous and Mental Disease 2007, 195:203-210.
7. Davis L.L., Wisniewski S.R., Howland R.H., Trivedi M.H., Husain M.M., Fava M., McGrath P.J., Balasubramani G.K., Warden D., Rush A.J. Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*|D level on treatment outcomes. Drug and Alcohol Dependence 2010, 107:161-170.
8. Fava G.A., Ruini C., Belaise C. The concept of recovery in major depression. Psychological Medicine 2007, 37:307-317.
9. First M.B., Spitzer R.L., Gibbon M., Williams J.B. User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders Research Version (SCID-I) 1996, New York State Psychiatric Institute, Biometrics Research, New York, NY.
10. Frank E., Carpenter L.L., Kupfer D.J. Sex differences in recurrent depression: are there any that are significant?. American Journal Psychiatry 1988, 145:41-45.
11. Glassman A.H., Perel J.M., Shostak M., Kantor S.J., Fleiss J.L. Clinical implications of imipramine plasma levels for depressive illness. Archives of General Psychiatry 1977, 34:197-204.
12. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised 1976, National Institute of Mental Health, Rockville, MD.
13. Halbreich U., Smoller J.W. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. Journal of Clinical Psychiatry 1997, 58:399-402.
14. Halbreich U., Rojansky N., Palter S., Twoek H., Hissin P., Wang K. Estrogen augments. Serotonergic activity in postmenopausal women. Biological Psychiatry 1995, 37:434-441.
15. Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology 1959, 32:50-55.
16. Hamilton M. A rating scale for depression. Journal of Neurology and Neurosurgery Psychiatry 1960, 23:56-62.
17. Hamilton J.A., Grant M., Jensvold M.F. Sex and treatment of depression. Psychopharmacology and Women: Sex, Gender, and Hormones 1996, 241-260. American Psychiatric Association Press, Washington, DC. M.J. Jensvold, U. Halbreich, J.A. Hamilton (Eds.).
18. Hildebrandt M.G., Steyerberg E.W., Stage K.B., Passchier J., Kragh-Soerensen P. Danish University Antidepressant Group. Are gender differences important for the clinical effects of antidepressants?. American Journal of Psychiatry 2003, 160:1643-1645.
19. Judd L.L., Paulus M.J., Schettler P.J., Akiskal H.S., Endicott J., Leon A.C., Maser J.D., Mueller T., Solomon D.A., Keller M.B. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?. American Journal of Psychiatry 2000, 157:1501-1504.
20. Kendall D.A., Stancel G.M., Enna S.J. The influence of sex hormones on antidepressant-induced alterations in neurotransmitter receptor binding. Journal of Neuroscience 1982, 2:354-360.
21. Kessler R.C., McGonagle K.A., Swartz M., Blazer D.G., Nelson C.B. Sex and depression in the National Comorbidity Survey I. Lifetime prevalence, chronicity, and recurrence. Journal of Affective Disorder 1993, 29:77-84.
22. Kessler R.C., McGonagle K.A., Zhao S., Nelson S., Hughes M., Eshleman S., Wittchen H.U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry 1994, 51:8-19.
23. Kim J.M., Stewart R., Glozier N., Prince M., Kim S.W., Yang S.J., Shin I.S., Yoon J.S. Physical health, depression and cognitive function as correlates of disability in an older Korean population. International Journal of Geriatric Psychiatry 2005, 20:160-167.
24. Kornstein S.G. Gender differences in depression: implications for treatment. Journal of Clinical Psychiatry 1997, 58(suppl 15):12-18.
25. Kornstein S.G. Premenstrual syndrome: an overview. Primary Psychiatry 1997, 4:56-60.
26. Kornstein S.G., Wojcik B.A. Gender effects in the treatment of depression. Psychiatric Clinics North America: Annual of Drug Therapy 2000, 7:23-57.
27. Kornstein S.G., Schatzberg A.F., Thase M.E., Yonkers K.A., McCullough J.P., Keitner G.I., Gelenberg A.J., Davis S.M., Harrison W.M., Keller M.B. Gender differences in treatment response to sertraline versus imipramine in chronic depression. American Journal of Psychiatry 2000, 157:1445-1452.
28. Kornstein S.G., Schatzberg A.F., Thase M.E., Yonkers K.A., McCullough J.P., Keitner G.I., Gelenberg A.J., Ryan C.E., Hess A.L., Harrison W., Davis S.M., Keller M.B. Gender differences in chronic major and double depression. Journal of Affective Disorder 2000, 60:1-11.
29. Kuehner C. Gender differences in unipolar depression: an update of epidemiological findings and possible explanations. Acta Psychiatrica Scandinavica 2003, 108:163-174.
30. Lee J.Y., Cho M.J., Kwon J.S. Global assessment of functioning scale and social and occupational functioning scale. Korean Journal of Psychopharmacology 2006, 17:122-127.
31. Lingjaerde O., Ahlfors U.G., Bech P., Dencker S.J., Elgen K. The UKU side effect rating scale: a new comprehensive rating scale for psychotropic drugs, and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatrica Scandinavica Supplementum 1987, 334:1-100.
32. Marcus S.M., Young E.A., Kerber K.B., Kornstein S., Farabaugh A.H., Mitchell J., Wisniewski S.R., Balasubramani G.K., Trivedi M.H. Gender differences in depression: findings from the STAR*D study. Journal of Affective Disorder 2005, 87:141-150.
33. Nolen-Hoeksema S. Sex Differences in Depression 1990, Stanford University Press, Stanford, CA.
34. Pande A., Birkett M., Fechner-Bates S., Haskett R.F., Greden J.F. Fluoxetine versus phenelzine in atypical depression. Biological Psychiatry 1996, 40:1017-1020.
35. Prange A.J., Wilson I.C., Rabon A.M., Lipton M.A. Enhancement of imipramine antidepressant activity by thyroid hormone. American Journal of Psychiatry 1969, 126:457-469.
36. Quitkin F.M., Stewart J.W., McGrath P.J., Tricamo E., Rabkin J.G., Ocepek-Welikson K., Nunes E., Harrison W., Klein D.F. Columbia atypical depression: a subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo. British Journal of Psychiatry Supplement 1993, 21:30-34.
37. Quitkin F.M., Stewart J.W., McGrath P.J., Taylor B.P., Tisminetzky M.S., Petkova E., Chen Y., Ma G., Klein D.F. Are there differences between women's and men's antidepressant responses?. American Journal of Psychiatry 2002, 159:1848-1855.
38. Raskin A. Age-sex differences in response to antidepressant drugs. Journal of Nervous and Mental Disease 1974, 159:120-130.
39. Regier D.A., Narrow W.E., Rae D.S., Mandersheid R.W., Locke B.Z., Goodwin F.K. The de facto U.S. mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Archives of General Psychiatry 1993, 50:85-94.
40. Sargeant J.K., Bruce M.L., Florio L.P., Weissman M.M. Factors associated with 1-year outcome of major depression in the community. Archives of General Psychiatry 1990, 47:519-526.
41. Schneider L.S., Small G.W., Hamilton S., Bystritsky A., Nemeroff C.B., Meyers B.S. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. American Journal of Geriatric Psychiatry 1997, 5:97-106. Fluoxetine Collaborative Study Group.
42. Thase M.E., Frank E., Kornstein S.G., Yonkers K.A. Gender differences in response to treatments of depression. Gender and Its Effects on Psychopathology 2000, 103-129. American Psychiatric Association Press, Washington, DC. E. Frank (Ed.).
43. Thase M.E., Entsuah R., Cantillon M., Kornstein S.G. Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions. Journal of Women's Health (Larchmt) 2005, 14:609-616.
44. Thiels C., Linden M., Grieger F., Leonard J. Gender differences in routine treatment of depressed outpatients with the selective serotonin reuptake inhibitor sertraline. International Clinical Psychopharmacology 2005, 20:1-7.
45. Weissman M.M., Bland R.C., Canino G.J., Faravelli C., Greenwald S., Hwu H.G., Joyce P.R., Karam E.G., Lee C.K., Lellouch J., Lepine J.P., Newman S.C., Rubio-Stipec M., Wells J.E., Wickramaratne P.J., Wittchen H., Yeh E.K. Cross-national epidemiology of major depression and bipolar disorder. Journal of the American Medical Association 1996, 276:293-299.
46. Winokur G., Coryell W., Keller M., Endicott J., Akiskal H. A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Archives of General Psychiatry 1993, 50:457-465.
47. Yi J.S., Bae S.O., Ahn Y.M., Park D.B., Noh K.S., Shin H.K., Woo H.W., Lee H.S., Han S.I., Kim Y.S. Validity and reliability of the Korean version of the Hamilton Depression Rating Scale (K-HDRS). Journal of Korean Neuropsychiatric Association 2005, 44:456-465.
48. Young E.A., Kornstein S.G., Marcus S.M., Harvey A.T., Warden D., Wisniewski S.R., Balasubramani G.K., Fava M., Trivedi M.H., Rush A.J. Sex differences in response to citalopram: a STAR*D report. Journal of Psychiatric Research 2009, 43:503-511.
49. Zimmerman M., Mattia J.I., Posternak M.A. Are subjects in pharmacological treatment trials representative of patients in routine clinical practice. American Journal of Psychiatry 2002, 159:469-473.